FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 189 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280,548 | -56.4% | 132,334 | -2.2% | 0.00% | -66.7% |
Q2 2023 | $644,190 | -17.7% | 135,334 | -1.5% | 0.00% | +50.0% |
Q1 2023 | $783,129 | +389.1% | 137,391 | +765.7% | 0.00% | – |
Q4 2022 | $160,128 | -55.0% | 15,870 | -0.1% | 0.00% | -100.0% |
Q3 2022 | $356,000 | -10.6% | 15,880 | -1.2% | 0.00% | 0.0% |
Q2 2022 | $398,000 | -38.2% | 16,073 | -3.2% | 0.00% | 0.0% |
Q1 2022 | $644,000 | -40.7% | 16,603 | -10.6% | 0.00% | -50.0% |
Q4 2021 | $1,086,000 | +0.3% | 18,565 | +1.6% | 0.00% | -33.3% |
Q3 2021 | $1,083,000 | -36.1% | 18,274 | -6.5% | 0.00% | -25.0% |
Q2 2021 | $1,695,000 | +3.6% | 19,534 | -1.6% | 0.00% | -20.0% |
Q1 2021 | $1,636,000 | -11.7% | 19,846 | -2.6% | 0.01% | -16.7% |
Q4 2020 | $1,853,000 | +144.1% | 20,380 | +7.4% | 0.01% | +100.0% |
Q3 2020 | $759,000 | +120.6% | 18,979 | +89.6% | 0.00% | +50.0% |
Q2 2020 | $344,000 | -0.6% | 10,012 | -35.8% | 0.00% | 0.0% |
Q1 2020 | $346,000 | +13.4% | 15,592 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $305,000 | +48.8% | 15,592 | +17.8% | 0.00% | 0.0% |
Q3 2019 | $205,000 | -73.2% | 13,232 | -64.8% | 0.00% | -75.0% |
Q2 2019 | $764,000 | +15.6% | 37,632 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $661,000 | +36.9% | 37,632 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $483,000 | – | 37,632 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |